MicroRNA-155 deficiency leads to decreased atherosclerosis, increased white adipose tissue obesity, and non-alcoholic fatty liver disease: a novel mouse model of …
Obesity paradox (OP) describes a widely observed clinical finding of improved
cardiovascular fitness and survival in some overweight or obese patients. The molecular …
cardiovascular fitness and survival in some overweight or obese patients. The molecular …
Anti-inflammatory actions of soluble Ninjurin-1 ameliorate atherosclerosis
Background: Macrophages produce many inflammation-associated molecules, released by
matrix metalloproteinases, such as adhesion molecules, and cytokines, as well, which play a …
matrix metalloproteinases, such as adhesion molecules, and cytokines, as well, which play a …
Novel iron oxide–cerium oxide core–shell nanoparticles as a potential theranostic material for ROS related inflammatory diseases
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are key signaling
molecules that play an important role in the inflammation and progression of many diseases …
molecules that play an important role in the inflammation and progression of many diseases …
The anti-inflammatory effects of formononetin and ononin on lipopolysaccharide-induced zebrafish models based on lipidomics and targeted transcriptomics
L Luo, J Zhou, H Zhao, M Fan, W Gao - Metabolomics, 2019 - Springer
Introduction Formononetin (MBHS) and its glycosylated derivative ononin (MBHG), as the
major isoflavones, have exhibited the anti-inflammatory impacts on the lipopolysaccharide …
major isoflavones, have exhibited the anti-inflammatory impacts on the lipopolysaccharide …
Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation
Innate immune cells express danger-associated molecular pattern (DAMP) receptors, T-cell
costimulation/coinhibition receptors, and major histocompatibility complex II (MHC-II). We …
costimulation/coinhibition receptors, and major histocompatibility complex II (MHC-II). We …
Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease
CW Yun, SH Lee - International journal of molecular sciences, 2019 - mdpi.com
Cardiovascular disease usually triggers coronary heart disease, stroke, and ischemic
diseases, thus promoting the development of functional failure. Mesenchymal stem cells …
diseases, thus promoting the development of functional failure. Mesenchymal stem cells …
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
S Wang, H He, Y Mao, Y Zhang, N Gu - Advanced Science, 2024 - Wiley Online Library
Atherosclerosis, a multifaceted chronic inflammatory disease, has a profound impact on
cardiovascular health. However, the critical limitations of atherosclerosis management …
cardiovascular health. However, the critical limitations of atherosclerosis management …
Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis
Importance Inflammatory pathways of psoriasis share similarities with the mechanisms
identified in atherosclerosis, and the association between psoriasis and cardiovascular …
identified in atherosclerosis, and the association between psoriasis and cardiovascular …
Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis
Atherosclerosis is a major underlying cause of cardiovascular disease. Although certain
success has been achieved in treatment for atherosclerosis, the risk of cardiovascular …
success has been achieved in treatment for atherosclerosis, the risk of cardiovascular …
Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of …
W Chang, F Zhu, H Zheng, Z Zhou, P Miao, L Zhao… - Molecular …, 2019 - Elsevier
Atherosclerosis is a common comorbidity of type II diabetes and a leading cause of death
worldwide. The presence of oxidized low-density lipoprotein (ox-LDL) drives atherogenesis …
worldwide. The presence of oxidized low-density lipoprotein (ox-LDL) drives atherogenesis …